SCHEMBL2640188

SCHEMBL2640188

CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H]([C]=O)C1CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
REN P00797 1/20 0.44
MMP1 P03956 2/20 0.41
MMP9 P14780 2/20 0.41
MMP14 P50281 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 1/20 0.38
ALOX15 P16050 1/20 0.38
MMP2 P08253 3/20 0.38
CTSK P43235 1/20 0.38
MMP3 P08254 1/20 0.38
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
CTSD P07339 2/20 0.36
BACE1 P56817 2/20 0.36
BCHE P06276 1/20 0.36
MAPK1 P28482 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4044570 0.81 CA12 (0.40) ALDH1A1SMN1; SMN2MMP2CA12CA1
SCHEMBL4041124 0.79 CA12 (0.37) ALDH1A1SMN1; SMN2MMP2CA12CA1
SCHEMBL5669457 0.77 BACE1 (0.40) CTSDBACE1
SCHEMBL14157321 0.74 MMP2 (0.38) MMP1MMP9MMP14MMP2MMP3
SCHEMBL28208197 0.74 MMP2 (0.38) MMP1MMP9MMP14MMP2MMP3
SCHEMBL3365403 0.73 ALDH1A1 (0.55) ALDH1A1MMP1MMP9MMP14SMN1; SMN2
SCHEMBL3834367 0.73 ALDH1A1 (0.55) ALDH1A1MMP1MMP9MMP14SMN1; SMN2
SCHEMBL30499267 0.70 MMP9 (0.41) RENMMP1MMP9MMP14SMN1; SMN2
SCHEMBL13035821 0.69 CA12 (0.61) MMP2CA12CA1CA2CA9
SCHEMBL251692 0.69 ALDH1A1 (0.67) ALDH1A1MMP9MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4745230-B2 2011-08-10 JP claimed
JP-2008500265-A 2008-01-10 JP claimed
EP-1646642-A2 INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE Vertex Pharmaceuticals Incorporated (US) 2006-04-19 EP claimed
WO-2005007681-A9 INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE 2006-04-06 WO claimed
WO-2005007681-A2 INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-01-27 WO claimed
WO-2005007681-A9 INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE 2006-04-06 WO disclosed